ASH Letter to FDA on Real-World Evidence Considerations re Non-Interventional Studies for Products

American Society of Hematology. (2024).
ASH Letter to FDA on Real-World Evidence Considerations re Non-Interventional Studies for Products.
Retrieved from https://www.hematology.org/advocacy/testimony-and-correspondence/ash-letter-to-fda-on-real-world-evidence-considerations-re-non-interventional-studies-for-products.

American Society of Hematology.
"ASH Letter to FDA on Real-World Evidence Considerations re Non-Interventional Studies for Products." Hematology.org.
https://www.hematology.org/advocacy/testimony-and-correspondence/ash-letter-to-fda-on-real-world-evidence-considerations-re-non-interventional-studies-for-products
(label-accessed April 30, 2025).

"American Society of Hematology."
ASH Letter to FDA on Real-World Evidence Considerations re Non-Interventional Studies for Products, 30 Apr. 2025 ,
https://www.hematology.org/advocacy/testimony-and-correspondence/ash-letter-to-fda-on-real-world-evidence-considerations-re-non-interventional-studies-for-products.

Citation Manager Formats

• BibLaTeX
• Bookends
• EasyBib
• EndNote
• Mendeley
• Papers
• RIS
• Ref Manager
• RefWorks
• Zotero